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The positions of seeds on
intraoperative transrectal ul-
trasonography and C-arm
cone beam computed to-
mography were automati-
cally linked for a large group
of 699 permanent prostate
implants. The corresponding
displacements and the effects
on dosimetry were calcu-
lated, intraoperatively and on
day 30. Edema seemed to
cause systematic dose dif-
ferences between the intra-
operative dosimetry and the
day 30 dosimetry, which can
be compensated for using a
simple equation. The largest
seed displacements were
observed near the rectum,
probably induced by the
transrectal ultrasound probe.Reprint requests to: Hendrik Westendor
Medical Physics, Radiotherapiegroep Behand
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http://dx.doi.org/10.1016/j.ijrobp.2016.04.015Purpose: We sought to identify the intraoperative displacement patterns of seeds and
to evaluate the correlation of intraoperative dosimetry with day 30 for permanent pros-
tate brachytherapy.
Methods and Materials: We analyzed the data from 699 patients. Intraoperative
dosimetry was acquired using transrectal ultrasonography (TRUS) and C-arm cone
beam computed tomography (CBCT). Intraoperative dosimetry (minimal dose to
40%-95% of the volume [D40-D95]) was compared with the day 30 dosimetry for
both modalities. An additional edema-compensating comparison was performed
for D90. Stranded seeds were linked between TRUS and CBCT using an automatic
and fast linking procedure. Displacement patterns were analyzed for each seed im-
plantation location.
Results: On average, an intraoperative (TRUS to CBCT) D90 decline of
10.6%  7.4% was observed. Intraoperative CBCT D90 showed a greater correla-
tion (R2Z 0.33) with respect to Day 30 than did TRUS (R2Z 0.17). Compensating
for edema, the correlation increased to 0.41 for CBCT and 0.38 for TRUS. The
mean absolute intraoperative seed displacement was 3.9  2.0 mm. The largest
seed displacements were observed near the rectal wall. The central and posterior
seeds showed less caudal displacement than lateral and anterior seeds. Seeds that
were implanted closer to the base showed more divergence than seeds close to
the apex.
Conclusions: Intraoperative CBCT D90 showed a greater correlation with the day 30
dosimetry than intraoperative TRUS. Edema seemed to cause most of the systematic
difference between the intraoperative and day 30 dosimetry. Seeds near the rectal
wall showed the most displacement, comparing TRUS and CBCT, probably becausep, MSc, Department of
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International guidelines have recommended dosimetry for
permanent 125I prostate implants 1 month after the implan-
tation procedure, when prostate swelling from edema has
resolved (1-4). The dosimetry at day 30 correlates with the
clinical treatment outcome (1, 5-7). However, it is difficult to
predict the day 30 dosimetry during the implantation pro-
cedure (4, 8-13). Factors such as contouring and registration
inaccuracies (14), edema (15), transrectal ultrasound (TRUS)
probeeinduced deformation (16), and difficult localization
of implanted seeds using TRUS (13) can lead to a hampered
estimate of the delivered dose to the prostate and organs at
risk (17). Edema affects dosimetry already during the im-
plantation procedure (18).
Furthermore, during implantation, the seeds can move,
which cannot be accurately visualized using TRUS (12, 13,
19). Therefore, TRUS-based live procedures have limited
capability of capturing the final positions of the seeds. An
accurate intraoperative identification of all final seed posi-
tions will potentially lead to a better prediction of the day
30 dosimetry.
In the present study, we analyzed the systematic patterns
of edema and seed displacements. This is only feasible if
the data processing is fully automated. Therefore, we
developed an automated registration method that links the
stranded seeds between the different image sets of the
permanent prostate implants (20).
The purpose of the present study was to assess the intra-
operative edema, quantify the seed displacements, and eval-
uate the corresponding effects on the dosimetry. We
compared intraoperative C-arm cone beam computed to-
mography (CBCT)ebased seed localization and dosimetry
with standard TRUS-based observations, using our automated
procedure. We quantified the geometric and dosimetric con-
sequences of intraoperative edema and the differences in seed
localization between TRUS and CBCT for 699 patients and
related these findings to the day 30 dosimetry.Methods and Materials
Patients
From October 2007 to June 2012, 740 patients with prostate
cancer who had undergone 125I seed implantation were
eligible for the present study. The prescribed dose was
145 Gy for the patients receiving monotherapy (81%). Pa-
tients receiving a boost after external beam radiation therapy
(19%) were prescribed 110 Gy. Excluded were those patients
who had not received a standard treatment or who hadundergone transurethral resection of the prostate before
implantation. Of the 740 patients, 41 had an incomplete
image data set, leaving 699 cases available for analysis.
Implantation procedure
A preplan was made using a treatment planning system
(TPS; Variseed, version 7.1-8.0.2; Varian Medical Systems,
Inc, Palo Alto, CA) approximately 2 weeks before the
implantation procedure to determine the appropriate source
strength and number of seeds to order.
In the operating room, 4 fiducial gold markers,
⌀1.0  5.0 mm (Heraeus GmbH, Hanau, Germany) were
placed using 2 needles. Using the left needle, the markers
were placed near the base and apex, and using the right
needle, the markers were placed near the midplane and base
of the prostate. The fiducial markers showed improved
visibility compared with the seeds, facilitating (rigid)
image registration.
Subsequently, the preplan was adjusted to the actual
prostate size and shape at the moment of implantation using
a TRUS scan (Falcon 2101 EX and Flex Focus 400; BK
Medical, Herlev, Denmark) with 5-mm spaced slices.
The periphery of the prostate was implanted with
stranded seeds clockwise, viewed from the observer, as
shown in Figure 1A. After placing all the peripheral
needles, the seeds were deposited. The position of the
deposited strands was manually determined using trans-
versal and sagittal TRUS imaging, the seeds were indi-
vidually digitized. The dose distribution was updated, and
the number and location of the seeds to be placed poste-
riorly was planned, placed, and recorded. The planning
was repeated for the central positions, and the implant was
finished.
A final dose distribution was calculated using the pre-
implant TRUS contours (Table 1). On average, 72  8 seeds
were implanted. Stranded seeds with a strength of 0.419 to
0.876 U and dimensions of 0.8  4.6 mm were used (IBt
1251L, Seneffe, Belgium; IBt-Bebig I25.S06, Berlin, Ger-
many; Bard STM1251, Murray Hill, NJ). Spacing between
seeds was equidistant (10 mm center to center) in most
strands. Strands with varying spacing were applied mainly to
the central locations (3 and 4 in Fig. 1A). Next, a new TRUS
scan was taken with 2.5-mm spaced slices and minimal
pressure to the rectal wall to limit deformation of the pros-
tate. The prostate was contoured again on this TRUS data
set. The TRUS probe was removed, the legs of the patient
were lowered, and a CBCT scan with 2.5-mm spaced slices
was acquired (Siemens Arcadis Orbic 3D; Siemens Medical
Systems, Erlangen, Germany). The CBCT scan was acquired











Fig. 1. (A) Implantation order: 1, periphery (circles); 2, posterior (crosses); 3, central right and left (triangles); 4, central
posterior (square). (B) Linking of seeds from cone beam computed tomography (circles) to transrectal ultrasonography
(stars), viewed caudally. The corresponding seeds in both distributions are linked by orange lines.
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CBCT and TRUS data sets were registered using the fiducial
gold markers, and the dosimetry was evaluated. If deemed
necessary, the implant was adapted by placing remedial
seeds (21).
Postimplant dosimetry was performed at day 30 using
CT (Brilliance CT Big Bore; Philips Healthcare, Best, The
Netherlands) to obtain the seed positions. For cases in
which an implant had been adapted in the operating room,
an additional postplan was created. In this postplan, the
source strength of the remedial seeds was set to 0, omit-
ting the dose contribution of the remedial seeds. The
present study focused on the intraoperative effects and
how these translated to the day 30 dosimetry. Therefore,
the contribution of the remedial seeds was omitted from
the day 30 dosimetry. Thus, the currently reported values
of intraoperative CBCT-based dosimetry and the dosimetry
at day 30 do not correspond to the actual values we
achieved.Table 1 Overview of analyses and data sources
Item Contours Seed positi
Intraoperative TRUS TRUS before implantation* TRUS intraope
Intraoperative CBCT TRUS after implantationy CBCT after
implantationz
Day 30 TRUS before implantation CT day 30
Abbreviations: CBCT Z cone beam computed tomography; CT Z c
ultrasonography.
* Intraoperatively acquired before implantation.
y Intraoperatively acquired immediately after implantation.
z Intraoperatively acquired after postimplant TRUS.
x Rigid registration using fiducial gold markers.The dosimetry at day 30 was based on the seed locations
on the day 30 CT scan and the preimplant contours on the
TRUS scan. Registration of both data sets was done by
matching the fiducial gold markers using the least squares
method of the TPS. If needed, the registration was manu-
ally adjusted. This method closely resembles the method
proposed by Bowes (22), with the major difference that we
used fiducial gold markers for the registration instead of the
urethra. A detailed description of our procedure has been
previously published (21).Analysis
The intraoperative dosimetry was compared with the day 30
dosimetry. In addition to a direct comparison, we determined
the relationship between the edema-compensated intra-
operative dosimetry and the day 30 dosimetry. The effect of
edema on the minimal dose to 90% of the volume (D90) wasInput
Analysesons Registration
ratively NA Edema, dosimetry, and
displacements
Least squares minimizationx Edema, dosimetry, and
displacements
Least squares minimization Edema, dosimetry











Fig. 2. The displacement patterns differed considerably by
slice and position. The reference positions of all 49,722 seeds
in transverse slices are depicted as dots. The colors of the
dots represent the displacement, from transrectal ultraso-
nography to cone beam computed tomography, in the cra-
niocaudal direction. For every needle in each slice, the
average in-plane displacements are shown as vectors with the
corresponding in-plane length (in millimeters) as a number.
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2 and attenu-
ation (r/rref)







where r is the mean distance of all seeds to their center of
mass (COM). The compensated D90 (D90 comp) was plotted
against the D90 of day 30 (reference, rref). Vx (percentage of
volume receiving the minimal x% of the prescribed dose)
does not scale with the radius. No compensation for Vx was
determined.
The seed positions obtained by intraoperative TRUS
were linked and registered to the seed positions acquired by
CBCT imaging using a strand-based algorithm that has
previously been described and evaluated in detail (20). The
registration of the TRUS- and CBCT-based seeds allowed
for translation and rotation. A typical result of the auto-
mated linking procedure is shown in Figure 1B. All seeds in
the CBCT distribution were linked to seeds in the TRUS
distribution. The displacements are visualized.
The differences in the linked seed positions (ie, dis-
placements) were analyzed. The TRUS-based seed positions
were taken as the reference to analyze the seed displace-
ments. In Figure 2, the reference seed positions of all im-
plants, plotted together, cluster at specific locations. These
locations resemble the coordinates of the commonly used
holes in the implantation template. The X (lefteright) and Y
(anteroposterior) coordinates of all seeds were plotted, and
19 clusters were identified. The seed positions were attrib-
uted to 1 of the clusters using K-means clustering (24).
The prostate was subdivided into 4 transversal slices
(Fig. 2). The slices coincided with the positions of the seeds
in the strands containing 4 seeds, which were the most
common. For each slice, the seeds were visualized by
plotting all the seed positions as dots, with colors showing
displacements in the craniocaudal direction. Per cluster, the
mean resulting in-plane displacement, in that slice, was
depicted as a vector.
Next, the individual clusters were displayed sagittally
(Fig. 3). Each cluster was subdivided in the Z (craniocau-
dal) direction in the number of seed positions in that cluster.
The centers of the seed clusters were determined visually,
and the seeds were assigned to these seed clusters using K-
means clustering. For each needle, all corresponding seed
clusters were analyzed. Each seed position was shown as a
dot in the ZeY plane, with the color representing the length
of the (3-dimensional) displacement. The mean ZeY
displacement of each seed cluster was visualized as a
vector. The analyses and corresponding data sources are
listed in Table 1.
Results
Dosimetry
Dosimetric data for 699 patients were obtained at day






















Fig. 3. Seed (cluster) displacements of transrectal ultrasonography to cone beam computed tomography. The location of
the corresponding needles, depicted in columns A and C, is shown in column B. Each dot represents a seed; the color shows
the corresponding (3-dimensional) length of the displacement. The vectors visualize the mean in-plane movement of each
cluster, with the length in millimeters.
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decline of 10.6%  7.4% (standard deviation, percentage of
the prescribed dose) for D90 and 5.1%  5.2% for V100 was
observed in the operating room comparing the CBCT-
acquired dosimetry with the TRUS-acquired dosimetry. On
day 30, D90 was 1.8%  8.5% lower than intraoperatively
using TRUS and 8.7%  8.0% greater than intraoperatively
using CBCT. The day 30 dosimetry showed, on average, a
2.6%  3.1% lower V100 compared with TRUS and a 2.4%
 4.5% greater V100 compared with CBCT.
Figure 4 shows the correlation of the intraoperative
dosimetry with the day 30 dosimetry. The intraoperative D90(based on TRUS and CBCT) was compared with the day 30
D90. The correlation of the D90 TRUS dosimetry showed an
R2 of 0.17. The CBCT dosimetry correlation showed an R2
of 0.33. In the lower row of the subfigures, D90 was
compensated for edema and attenuation were compensated
for using Equation 1. Compensating for edema by applying
Equation 1, the correlation (R2) increased to 0.38 and 0.41
for the TRUS- and CBCT-based D90, respectively. For all
correlations, a P value <<106 was found. For the
compensated situation, the linear regression slope was 0.89
for the TRUS-based and 1.01 for the CBCT-based dosim-
etry compared with the day 30 values.
Table 2 Dosimetry at days 0 and 30
Variable
Intraoperative (day 0) Day 30
TRUS CBCT CT
D40 154  9 148  10 164  14
D60 139  7 131  9 144  11
D80 125  5 119  8 127  10
D90 118  5 107  8 116  9
D90 comp. 122  13 119  15 116  9
D95 113  5 101  9 107  9
V100 99.5  1.1 94  5 97  3
V150 44  10 37  10 53  12
UD30 119  6 116  10 137  15
VProstate (cm
3) 39  11 39  11 38  11
Abbreviations: CBCT Z cone beam computed tomography; CT Z
computed tomography; Dx Z minimal percentage of prescribed dose
to x% of the prostate; D90 comp.Zminimal dose to 90% of the prostate,
with edema compensated for using Equation 1; TRUS Z transrectal
ultrasonography; UD30 Z Minimal percentage of prescribed dose to
30% of the urethra; VxZ percentage of volume receiving minimal x%
of the prescribed dose.
Data presented as mean  standard deviation.
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In total, 49,722 seeds were linked between TRUS (refer-
ence) and CBCT. An average displacement (vector length)
of 3.9  2.0 mm was observed. Relative to the COM, the
standard deviation of the displacements was 1.8 mm in the
lefteright, 2.1 mm in the anteroposterior, and 3.4 mm in
the craniocaudal direction. The relative distance to the
COM (r/rref) was 1.01  0.04 for TRUS and 1.04  0.04 for
CBCT compared with day 30. After scaling the distribution
to account for edema, the mean displacement vector length
decreased from 3.9 to 3.7 mm.
Figure 2 shows the displacements, between TRUS and
CBCT, in 4 equidistant transverse slices. The seeds
diverged more from the central axis when deposited more
toward the base. The seeds in the base slice displaced
caudally with an average of 0.6  3.2 mm. This was mainly
caused by the seeds in the anterior outer ring. The seeds in
the apex showed a mean displacement of 0.8  3.5 mm
cranially, predominantly caused by the central and posterior
seeds in the apex slice. The linking algorithm compensates
for rotation (20), resulting in a residual rotation of 0.
The displacement is shown in Figure 3 for each needle
and corresponding seed cluster separately. The position of
the left and right needles (symmetric) are depicted with the
identification number of both needle positions in the central
column. On the left and right side, the seeds assigned to the
corresponding needles are displayed as dots. The color il-
lustrates the total displacement of each seed. The vectors
visualize the mean displacement of each cluster in the
anteroposterior and craniocaudal directions. The corre-
sponding length of each vector is presented as a number.
Needles 1 to 11 and 14 were subdivided into 4 clusters; in
needles 12 and 13, 5 clusters were identified; and in the
central needles (needles 15-19), 2 clusters were defined.The least displacement was observed in the central seed
clusters of needles 4 to 7, with a mean displacement of
3.1  1.5 to 3.4  2.0 mm. The most displacement was
observed in needles 12, 13, and 19. The clusters in needle
19 presented with a mean displacement of 5.1  3.0 mm;
the basal cluster displacement equaled 4.5 mm. The outer
clusters in needle 12 and 13 showed displacements of
4.6  2.2 mm. Seeds displaced depending on their position.
In the outer ring (needles 2-9), the seeds displaced pre-
dominantly caudally (Fig. 3).Discussion
The present study is the first to show the displacement of
seeds and the dosimetric consequences during the implan-
tation procedure for a large group of patients (nZ699). The
size of the group allowed the investigation of the systematic
displacement patterns of seeds.
Differences in dosimetry were observed for the intra-
operative acquisitions with TRUS and CBCT and the
postoperative dosimetry at day 30 (Table 2). The systematic
difference in D90 can be attributed to the presence of
edema. A simple model compensating for the inverse
square law and attenuation (Eq. 1) seems to explain the
systematic difference between day 0 and day 30 (Fig. 4).
Furthermore, after compensating for the edema, the CBCT-
based dosimetry showed a better correlation for D90 at day
30 than did the TRUS-based dosimetry (Fig. 4). However,
this improved correlation does not allow for individual,
CBCT-based dosimetry predictions for day 30.
Random differences were not reduced after edema
compensation. The simple spherical model cannot
compensate for the nonuniform displacements shown in
Figures 2 and 3 and decreased the mean displacement by
only 0.2 mm. Also, stranded seeds might, because of strand
rigidity, respond differently to prostatic edema in the cra-
niocaudal direction than in the lateral directions. We have
previously shown that this effect is fairly limited (25).
However, loose seed implants could show slightly different
edema. Consequently, residual displacements would still
affect the dosimetry, just as would seed identification,
contouring, registration uncertainties, and movement in the
implantation channels.
Using the linking method (20), we linked the seed posi-
tions in the TRUS and CBCT data sets and quantified the
corresponding displacements. A rigid registration between
the TRUS and CBCT data sets minimized the distance be-
tween the seeds. The minimization of the distance between
the seeds in both data sets could have resulted in an over-
compensation of the displacement patterns. For example, if
all the seeds would show displacement in the caudal direc-
tion, this would have been compensated for by an equal
translation. This was verified by comparing the seed posi-
tions with the prostate contours. The physician contoured the
prostate before and after implantation. We evaluated whether
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Fig. 4. Correlation of intraoperative transrectal ultrasonography (TRUS) (A, C) and cone beam computed tomography
(CBCT) (B, D) for minimal dose to 90% of the volume (D90) with the day 30 D90. Figs. A (R
2Z 0.17) and B (R2Z 0.33)
represent raw data, and Figs. C (R2 Z 0.38) and D (R2 Z 0.41) represent data compensated (D90 comp.) for edema effects
using Equation 1. The linear regression for each situation is plotted as a solid black line. For comparison purposes, a unity
line (dashed line) is shown.
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We did not find indications for systematic shifts.
Figures 2 and 3 show the lefteright symmetry of the
displacement patterns. The pattern of displacements, as
visualized by the vectors, was continuous, with the neigh-
boring clusters showing similar displacement.
Displacements originate from multiple underlying
mechanisms. Among others, the following were found to
play a role. The first factor was the pressure of the ultra-
sound probe on the prostate. This pressure was minimized
but does still deform the prostate, as shown previously by
Liu et al (16). Seeds near the rectum (probe) will displace
to the posterior near the prostate base and to the anterior
near the prostate apex. TRUS probeeinduced prostate
deformation affects the seeds’ positions and the prostate
shape. Liu et al (16) reported that dosimetry changes due to
TRUS probe removal mainly resulted from changes in seed
position and, to a lesser extent, contour changes. Thesecond factor was that the posterior needles, placed close to
the rectum, were intentionally placed at an angle, using the
beveled needle tip, to follow the prostateerectum interface.
The TPS did not allow angles for strands on the real-time
TRUS images. For the CT image data sets, angles were
allowed. This amplifies the effect of the ultrasound probe.
Finally, the presence of edema will move seeds away from
the COM.
Edema is difficult to predict but it results in considerable
consequences on the dosimetry during the implantation
procedure. This effect has also been observed by other
groups that compared the dosimetry shortly after implan-
tation with the day 30 dosimetry (26, 27). The amount of
edema observed in the present study agreed well with the
results from an earlier study in which we reported a
spherical volume change of 12%, corresponding to an
ðr=rref Þ of 1.04 (25). The contoured prostate volumes
(Table 2) did not show this amount of edema. This could
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sets and the tendency to contour an additional slice to
ensure full target coverage. The wider slice spacing (5 vs
2.5 mm) of the preimplant TRUS scan could have led to an
overestimation of the volume and might have hidden the
volume increase due to the presence of edema.
The use of stranded seeds might lead to an underesti-
mation of edema in the craniocaudal direction. Loose seeds
might show more edema, but this would not challenge the
qualitative observations.
The anteriorelateral outer ring of seeds displaced
caudally. In contrast, the central and outer posterior seeds
displaced cranially. This could be an indication that the
implantation (Fig. 1A) order affects the displacements.
However, comparing the left and right needle positions
(Fig. 3), we did not observe differences between the earlier
and later placed seeds. Therefore, we do not believe that the
displacement of seeds is directly related to the order of
implantation.
Published data have indicated that underdosage occurs
predominantly at the base of the prostate (8, 28, 29).
Edema, needle divergence, and the caudal displacement of
the (outer) seeds could result in underdosage in that region.
If seeds have been not accurately identified during the
implantation procedure, the underdosage will remain un-
noticed. This could result in underdosage at day 30. An
adaptive brachytherapy procedure that includes CBCT
might thus help to improve the dosimetry. Further investi-
gation of the consequences of adaptive brachytherapy is
needed for verification.
The implantation technique could be slightly modified to
anticipate the intraoperative displacement patterns. The
observed divergence of the needles could possibly be
lowered by implanting the needles in a slightly convergent
geometry. The displacements caused by TRUS probe
removal could be anticipated by placing the seeds near the
prostate base slightly more anteriorly than planned. The
seeds in the outer anterior ring could be implanted slightly
deeper. However, these suggestions depend on the im-
plantation technique, model of seeds and strands, and the
use of loose or stranded seeds.
Currently, interest in focal treatments is increasing.
Particularly for small lesions, accurate seed placement is
important (30); thus, knowing the displacement properties
could help in such procedures. In addition to implantation
technique enhancements, the TPS should allow for the
registration of nonparallel needles during the implantation
procedure.Conclusions
We visualized the intraoperative systematic displacements
for a large group of implants (nZ699) using an automated
analysis of 49,722 seeds on TRUS and CBCT. The
magnitude and orientation of displacements of seeds differ
considerably for various positions in the prostate. Seedsclose to the rectal wall showed the most displacement,
probably resulting from TRUS probeeinduced prostate
deformation. Seeds close to the base showed more diver-
gent displacements than seeds close to the apex. The cor-
responding dosimetry was assessed. The intraoperative
systematic difference in D90 seems to be predominantly
caused by edema. Compared with TRUS, the intraoperative
CBCT-based D90 showed a greater correlation with the day
30 dosimetry. Automated analysis is a prerequisite for the
results we obtained for this large group.
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